Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2020 Feb 9;188(4):586. doi: 10.1111/bjh.16352

Corrigendum

PMCID: PMC8097612  PMID: 32037518

In the article from Ma et al. (2019), the authors would like to update the acknowledgement section of this article. The updated acknowledgement section is shown below.

Acknowledgement

The authors would like to thank Dr. Hongliang Zong for his valuable research suggestions and technical support. This project is supported in part by Shanghai Pujiang Program (No. 17PJ1405500 to JM), Shanghai Natural Science Foundation (No. 17ZR1415600 to JM), National Natural Science Foundation of China (No. 81700134 to JM).

In addition to this, the affiliations of the second author Bin Liu should be as follows:

2Department of Haematology, Changhai Hospital of the Second Military Medical University, Shanghai, China and 3Department of Pulmonary & Critical Care Medicine, Chinese People’s Liberation Army (PLA) General Hospital, Beijing, China

Also, the following authors are co‐corresponding authors of this paper.

Jinke Cheng, Shanghai Jiao Tong University School of Medicine, 280 Chongqing South Road, Building 7, Shanghai, China, 200025.

email: jkcheng@shsmu.edu.cn

Jianmin Yang, Department of Haematology, Changhai Hospital of the Second Military Medical University, No. 168 Changhai Road, Shanghai, China, 200433.

email:chyangjianmin@163.com

The authors would like to apologise for the inconvenience caused.

Reference

  1. Ma, J. , Liu, B. , Yu, D. , Zuo, Y. , Cai, R. , Yang, J. & Cheng, J. (2019) SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation. British Journal of Haematology, 187, 49–64. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Haematology are provided here courtesy of Wiley

RESOURCES